PainReform Ltd
PRFX
View Detailed Chart
0.862USD
-0.021-2.33%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.74MMarket Cap
0.02P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.33%
5 Days
-9.32%
1 Month
-2.03%
6 Months
-41.51%
Year to Date
-74.30%
1 Year
-80.58%
View Detailed Chart
TradingKey Stock Score of PainReform Ltd
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at max_target_price.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
PainReform Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
PainReform Ltd Highlights
StrengthsRisks
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Overvalued
The company’s latest PE is 0.03, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 33.74K shares, decreasing 53.86% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.21.
PainReform Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
PainReform Ltd Info
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Ticker SymbolPRFX
CompanyPainReform Ltd
CEOHadar (Ilan)
Websitehttps://painreform.com/
FAQs
What is the current price of PainReform Ltd (PRFX)?
The current price of PainReform Ltd (PRFX) is 0.862.
What is the symbol of PainReform Ltd?
The ticker symbol of PainReform Ltd is PRFX.
What is the 52-week high of PainReform Ltd?
The 52-week high of PainReform Ltd is 6.650.
What is the 52-week low of PainReform Ltd?
The 52-week low of PainReform Ltd is 0.801.
What is the market capitalization of PainReform Ltd?
The market capitalization of PainReform Ltd is 1.74M.
What is the net income of PainReform Ltd?
The net income of PainReform Ltd is -14.59M.
Is PainReform Ltd (PRFX) currently rated as Buy, Hold, or Sell?
According to analysts, PainReform Ltd (PRFX) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of PainReform Ltd (PRFX)?
The Earnings Per Share (EPS TTM) of PainReform Ltd (PRFX) is 41.519.
Related Instruments
+0.41%
+0.94%
+0.51%
+0.34%
-0.17%
+1.42%
+0.75%
+1.80%
+0.38%
+0.66%
+0.08%
+0.82%
+0.81%
+0.08%
+0.23%
-0.05%
-0.19%
0.00%
+1.54%
+0.50%
